Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

Posts on ‘November 13th, 2009’

Phase II/III Medical Study Compares Safety and Efficacy of 2 Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic Insufficiency

PHILADELPHIA, PA - (HSMN NewsFeed) - Eurand N.V. (NASDAQ:EURX ), a global specialty pharmaceutical company, today announced data from a Phase II/III clinical study demonstrating that ZENPEP(TM) (pancrelipase) Delayed-Release Capsules significantly improves…
Biopharmaceuticals
Eurand, ZENPEP, pancrelipase, exocrine pancreatic insufficiency, pancreatitis

Millar Instruments and Harvard Apparatus Improve Ability to Provide Customers With Total Physiology Solutions Through Joint Distribution Agreement

ORLANDO, Fla., Nov. 13 (HSMN NewsFeed) — Millar Instruments, Inc. developer and manufacturer of Mikro-Tip® pressure transducer catheters and pressure-volume (P-V) systems and Harvard Apparatus, manufacturer of specialty life science equipment, today…
Devices, Distribution
Millar Instruments, Harvard Apparatus, Mikro-Tip, pressure transducer

Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor

INDIANAPOLIS, Nov. 13 (HSMN NewsFeed) — Eli Lilly and Company (NYSE: LLY ) announced today that Steven M. Paul, M.D., executive vice president, science and technology, and president, Lilly Research Laboratories, will retire from Lilly effective February…
Biopharmaceuticals, Personnel
Eli Lilly

Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE)

FARMINGDALE, N.Y., Nov. 13 (HSMN NewsFeed) — Misonix, Inc. (Nasdaq: MSON ), a developer of minimally invasive ultrasonic laboratory device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has e…
Devices, Surgery, Distribution
Misonix, Xenith, SonaStar, BoneScalpel, SonicOne, ultrasonic aspirator

Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck Cancer

Noted medical experts detail recent developments at the annual ASTRO meeting in Chicago PALO ALTO, Calif., Nov. 13 (HSMN NewsFeed) — Clinical studies suggest that advanced treatments like intensity-modulated radiotherapy (IMRT) and image-guided radi…
Devices, Oncology
Varian Clinical Systems, image-guided radiotherapy, IGRT, radiotherapy

Ipsen’s Decapeptyl(R) 6-Month Formulation Receives Marketing Authorization in France for the Treatment of Locally Advanced or Metastatic Prostate Cancer

PARIS–(HSMN NewsFeed)–Ipsen (Paris:IPN), an innovation-driven global specialty pharma Group announces that the French regulatory authorities (Agence Française de Sécurité Sanitaire des Produits de Santé, AFSSAPS) have …
Biopharmaceuticals, Oncology, Regulatory
Ipsen , Decapeptyl, triptorelin, prostate cancer